Deborah R. Kaye

1.3k total citations
68 papers, 856 citations indexed

About

Deborah R. Kaye is a scholar working on Economics and Econometrics, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Deborah R. Kaye has authored 68 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Economics and Econometrics, 25 papers in Pulmonary and Respiratory Medicine and 14 papers in Surgery. Recurrent topics in Deborah R. Kaye's work include Economic and Financial Impacts of Cancer (18 papers), Prostate Cancer Treatment and Research (13 papers) and Prostate Cancer Diagnosis and Treatment (11 papers). Deborah R. Kaye is often cited by papers focused on Economic and Financial Impacts of Cancer (18 papers), Prostate Cancer Treatment and Research (13 papers) and Prostate Cancer Diagnosis and Treatment (11 papers). Deborah R. Kaye collaborates with scholars based in United States, Canada and South Africa. Deborah R. Kaye's co-authors include Lindsey A. Herrel, Trinity J. Bivalacqua, Robert A. Berenson, Chad Ellimoottil, Peter A. Pinto, W. Marston Linehan, Max Kates, James M. Dupree, Gennady Bratslavsky and Karel Pacák and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Deborah R. Kaye

59 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah R. Kaye United States 18 346 207 158 115 111 68 856
Peter Haastrup Denmark 16 424 1.2× 176 0.9× 94 0.6× 77 0.7× 48 0.4× 48 844
Dong‐Sook Kim South Korea 15 259 0.7× 131 0.6× 153 1.0× 90 0.8× 67 0.6× 78 1.1k
Imtiaz A. Munshi United States 16 425 1.2× 186 0.9× 30 0.2× 53 0.5× 60 0.5× 42 1.1k
Jacques LeLorier Canada 16 166 0.5× 142 0.7× 77 0.5× 31 0.3× 50 0.5× 45 811
Susie Q. Lew United States 20 238 0.7× 240 1.2× 69 0.4× 70 0.6× 167 1.5× 93 1.2k
Taner Çamsarı Türkiye 18 169 0.5× 182 0.9× 23 0.1× 51 0.4× 30 0.3× 73 1.1k
Barrie S. Rich United States 16 382 1.1× 198 1.0× 23 0.1× 131 1.1× 37 0.3× 61 769
Patrick K. Kim United States 17 432 1.2× 97 0.5× 34 0.2× 81 0.7× 26 0.2× 30 987
Carly J. Paoli United States 11 126 0.4× 127 0.6× 144 0.9× 134 1.2× 104 0.9× 31 942
N Edward United Kingdom 17 197 0.6× 128 0.6× 139 0.9× 25 0.2× 60 0.5× 57 1.1k

Countries citing papers authored by Deborah R. Kaye

Since Specialization
Citations

This map shows the geographic impact of Deborah R. Kaye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah R. Kaye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah R. Kaye more than expected).

Fields of papers citing papers by Deborah R. Kaye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah R. Kaye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah R. Kaye. The network helps show where Deborah R. Kaye may publish in the future.

Co-authorship network of co-authors of Deborah R. Kaye

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah R. Kaye. A scholar is included among the top collaborators of Deborah R. Kaye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah R. Kaye. Deborah R. Kaye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaye, Deborah R., Laura J. Fish, Heather Parnell, et al.. (2025). Understanding the Causes of Nonadherence to Chronic Medications Among Patients With Cancer and Multimorbidity: A Qualitative Study . Journal of General Internal Medicine.
2.
Kaye, Deborah R., J. Kelly Davis, Sharron L. Docherty, et al.. (2024). Physician Perspectives on the Nonclinical Factors That Contribute to Decision-Making for Advanced Prostate Cancer Care: A Qualitative Study. JU Open Plus. 2(3).
3.
Kaye, Deborah R., Erik Muser, Laura Morrison, et al.. (2024). Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiation. Journal of Medical Economics. 27(1). 201–214. 2 indexed citations
4.
Kaye, Deborah R., Erik Muser, Laura Morrison, et al.. (2024). Characterizing the real-world economic burden of metastatic castration-sensitive prostate cancer in the United States. Journal of Medical Economics. 27(1). 381–391. 2 indexed citations
5.
Kaye, Deborah R., Erik Muser, Laura Morrison, et al.. (2024). Real-world economic burden associated with disease progression from metastatic castration-sensitive to castration-resistant prostate cancer on treatment in the United States. Journal of Managed Care & Specialty Pharmacy. 30(7). 684–697. 2 indexed citations
6.
Daignault‐Newton, Stephanie, Deborah R. Kaye, Heidi B. IglayReger, et al.. (2023). Use of a physical activity monitor to track perioperative activity of radical cystectomy patients. Our first glimpse at what our patients are doing before and after surgery. Urologic Oncology Seminars and Original Investigations. 41(4). 206.e11–206.e19. 2 indexed citations
7.
Berger, Ian, Vishnukamal Golla, Marcelo Cerullo, et al.. (2023). Rural For-Profit Hospitals Are Associated With Higher Commercial Prices for 3 Common Urological Procedures. Urology Practice. 10(6). 580–585. 1 indexed citations
8.
Wilson, Lauren E., Bradford E. Jackson, Lisa P. Spees, et al.. (2022). End-of-Life Care for Patients With Metastatic Renal Cell Carcinoma in the Era of Oral Anticancer Therapy. JCO Oncology Practice. 19(2). e213–e227. 1 indexed citations
9.
Spees, Lisa P., Michaela A. Dinan, Bradford E. Jackson, et al.. (2022). Patient- And Provider-Level Predictors of Survival Among Patients With Metastatic Renal Cell Carcinoma Initiating Oral Anticancer Agents. Clinical Genitourinary Cancer. 20(5). e396–e405. 4 indexed citations
10.
Dinan, Michaela A., Lauren E. Wilson, Melissa A. Greiner, et al.. (2022). Oral Anticancer Agent (OAA) Adherence and Survival in Elderly Patients With Metastatic Renal Cell Carcinoma (mRCC). Urology. 168. 129–136. 6 indexed citations
11.
George, Arvin K., et al.. (2022). Should Transperineal Prostate Biopsy Be the Standard of Care?. Current Urology Reports. 24(3). 135–142. 5 indexed citations
12.
Wilson, Lauren E., Melissa A. Greiner, Tian Zhang, et al.. (2022). Evaluation of mild cognitive impairment and dementia in patients with metastatic renal cell carcinoma. Journal of Geriatric Oncology. 13(5). 635–643. 3 indexed citations
13.
Spees, Lisa P., Stephanie B. Wheeler, Bradford E. Jackson, et al.. (2021). Provider‐ and patient‐level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma. Cancer Medicine. 10(19). 6653–6665. 3 indexed citations
14.
Ginsburg, Kevin, Ji Qi, Deborah R. Kaye, et al.. (2020). Impact of Early Confirmatory Tests on Upgrading and Conversion to Treatment in Prostate Cancer Patients on Active Surveillance. Urology. 147. 213–222. 7 indexed citations
15.
Ginsburg, Kevin, Ji Qi, Susan Linsell, et al.. (2019). Confirmatory Magnetic Resonance Imaging with or without Biopsy Impacts Decision Making in Newly Diagnosed Favorable Risk Prostate Cancer. The Journal of Urology. 201(5). 923–928. 3 indexed citations
16.
Kaye, Deborah R., Zaojun Ye, Jonathan Li, et al.. (2018). The Stability of Physician-Specific Episode Costs for Urologic Cancer Surgery: Implications for Urologists Under the Merit-Based Incentive Program. Urology. 123. 114–119. 3 indexed citations
17.
Ellimoottil, Chad, Jonathan Li, Zaojun Ye, et al.. (2017). Episode-based Payment Variation for Urologic Cancer Surgery. Urology. 111. 78–85. 14 indexed citations
18.
Chappidi, Meera R., Max Kates, Hiten D. Patel, et al.. (2016). Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy. Urologic Oncology Seminars and Original Investigations. 34(6). 256.e1–256.e6. 99 indexed citations
19.
Kaye, Deborah R., Jeffrey K. Mullins, H. Ballentine Carter, & Trinity J. Bivalacqua. (2014). Robotic surgery in urological oncology: patient care or market share?. Nature Reviews Urology. 12(1). 55–60. 27 indexed citations
20.
Kaye, Deborah R., Patrick C. Walsh, George J. Netto, Nilda González-Roibón, & Ronald Rodríguez. (2012). A 66-Year-old Man With Prostate-specific Antigen Recurrence and Lung Mass After Radical Prostatectomy. Urology. 80(2). 247–249.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Haastrup Breakdown of academic impact, for papers by Dong‐Sook Kim Breakdown of academic impact, for papers by Imtiaz A. Munshi Breakdown of academic impact, for papers by Jacques LeLorier Breakdown of academic impact, for papers by Susie Q. Lew Breakdown of academic impact, for papers by Taner Çamsarı Breakdown of academic impact, for papers by Barrie S. Rich Breakdown of academic impact, for papers by Patrick K. Kim Breakdown of academic impact, for papers by Carly J. Paoli Breakdown of academic impact, for papers by N Edward
Rankless by CCL
2026